IRX1 and lung adenocarcinoma: Subsequently, we analyzed the epigenetic inactivation of IRX1 in 100 lung adenocarcinoma (ADC) and 100 squamous cell carcinoma (SQCC) and the corresponding control samples by bisulfite pyrosequencing and quantitative RT-PCR (Figure 3).